Valuation: Photocure ASA

Market Cap 113.13Cr 12Cr 11Cr 9.86Cr 8.93Cr 17Cr 1.11TCr 17Cr 118.37Cr 47Cr 593.77Cr 44Cr 43Cr 1.89TCr P/E 2026 *
15x
P/E 2027 * 74.5x
Enterprise Value 100Cr 10Cr 9.44Cr 8.71Cr 7.88Cr 15Cr 981.08Cr 15Cr 104.56Cr 42Cr 524.49Cr 39Cr 38Cr 1.67TCr EV / Sales 2026 *
1.44x
EV / Sales 2027 * 1.45x
Free-Float
95.71%
Yield 2026 *
-
Yield 2027 * -
1 day-0.12%
1 week-5.63%
Current month-9.80%
1 month-15.35%
3 months-20.49%
6 months-33.60%
Current year-41.32%
1 week 41.5
Extreme 41.5
44.85
1 month 41.5
Extreme 41.5
50.8
Current year 41.5
Extreme 41.5
79.8
1 year 41.5
Extreme 41.5
79.8
3 years 41.5
Extreme 41.5
79.8
5 years 40.7
Extreme 40.7
122.7
10 years 21.5
Extreme 21.5
154.5
Manager TitleAgeSince
Chief Executive Officer - 01/11/2018
Chief Tech/Sci/R&D Officer - 01/08/2021
Human Resources Officer - 01/02/2021
Director TitleAgeSince
Director/Board Member - 01/01/2022
Chairman - 27/09/2023
Director/Board Member - 23/05/2024
Date Insider Type Main position Quantity % Market Cap. Importance
02/04/25 BuyCompany 11,355 0.0419%
02/04/25 BuyCompany 8,997 0.0332%
31/03/25 BuyCompany 27,113 0.1000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.12%-5.63%-28.62%-20.49% 12Cr
+0.00%+5.51%+41.47%+135.00% 1,28000Cr
+1.61%+4.54%+46.44%+92.83% 68TCr
+0.24%+2.64%+26.85%+113.39% 52TCr
+1.14%+3.78%+39.98%+70.26% 39TCr
+0.36%+0.54%+61.54%+44.17% 36TCr
+1.11%+0.07%+28.19%+58.61% 30TCr
+0.24%-0.80%+3.05%+35.93% 29TCr
+0.18%+1.99%+39.60%+76.02% 25TCr
-0.08%+1.27%+37.52%+126.48% 21TCr
Average +0.48%-1.13%+29.60%+73.22% 43TCr
Weighted average by Cap. +0.53%+0.20%+38.23%+96.24%

Financials

2026 *2027 *
Net sales 70Cr 7.27Cr 6.57Cr 6.07Cr 5.49Cr 10Cr 683.28Cr 11Cr 73Cr 29Cr 365.29Cr 27Cr 27Cr 1.16TCr 67Cr 6.97Cr 6.31Cr 5.82Cr 5.27Cr 9.94Cr 655.46Cr 10Cr 70Cr 28Cr 350.42Cr 26Cr 26Cr 1.12TCr
Net income 5.2Cr 54.3L 49.11L 45.33L 41.03L 77.42L 51Cr 79.74L 5.44Cr 2.16Cr 27Cr 2.04Cr 1.99Cr 87Cr 1.5Cr 15.66L 14.17L 13.08L 11.84L 22.33L 15Cr 23L 1.57Cr 62.37L 7.87Cr 58.79L 57.54L 25Cr
Net Debt -13Cr -1.38Cr -1.25Cr -1.15Cr -1.04Cr -1.97Cr -129.59Cr -2.02Cr -14Cr -5.49Cr -69Cr -5.17Cr -5.06Cr -220.51Cr -17Cr -1.73Cr -1.57Cr -1.45Cr -1.31Cr -2.47Cr -162.97Cr -2.55Cr -17Cr -6.9Cr -87Cr -6.51Cr -6.37Cr -277.31Cr
Projected Income Statement - Annual - Photocure ASA
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
12/26/12 NOK 41.90 -0.12% 94,840
11/26/11 NOK 41.95 +0.36% 96,748
10/26/10 NOK 41.80 -0.71% 99,801
09/26/09 NOK 42.10 -5.61% 1,99,502
06/26/06 NOK 44.60 +0.45% 1,26,301
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Photocure ASA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
41.95NOK
Average target price
75.00NOK
Spread / Average Target
+78.78%